Literature DB >> 32509827

Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma.

Julien Calderaro1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32509827      PMCID： PMC7262630          DOI： 10.21037/hbsn.2019.10.37

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

Review 1.  Hepatocellular Carcinoma.

Authors:  Augusto Villanueva
Journal:  N Engl J Med       Date:  2019-04-11       Impact factor: 91.245

2.  Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.

Authors:  Salvatore Lorenzo Renne; Ha Young Woo; Sarah Allegra; Noemi Rudini; Hirohisa Yano; Matteo Donadon; Luca Viganò; Jun Akiba; Hye Sun Lee; Hyungjin Rhee; Young Nyun Park; Massimo Roncalli; Luca Di Tommaso
Journal:  Hepatology       Date:  2019-08-09       Impact factor: 17.425

Review 3.  Molecular and histological correlations in liver cancer.

Authors:  Julien Calderaro; Marianne Ziol; Valérie Paradis; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2019-06-10       Impact factor: 25.083

4.  ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.

Authors:  Julien Calderaro; Léa Meunier; Cong Trung Nguyen; Marouane Boubaya; Stefano Caruso; Alain Luciani; Giuliana Amaddeo; Hélène Regnault; Jean-Charles Nault; Justine Cohen; Frédéric Oberti; Sophie Michalak; Mohamed Bouattour; Valérie Vilgrain; Georges Philippe Pageaux; Jeanne Ramos; Nathalie Barget; Boris Guiu; Valérie Paradis; Christophe Aubé; Alexis Laurent; Jean-Michel Pawlotsky; Nathalie Ganne-Carrié; Jessica Zucman-Rossi; Olivier Seror; Marianne Ziol
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

5.  Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Authors:  Marianne Ziol; Nicolas Poté; Giuliana Amaddeo; Alexis Laurent; Jean-Charles Nault; Frédéric Oberti; Charlotte Costentin; Sophie Michalak; Mohamed Bouattour; Claire Francoz; Georges Philippe Pageaux; Jeanne Ramos; Thomas Decaens; Alain Luciani; Boris Guiu; Valérie Vilgrain; Christophe Aubé; Jonathan Derman; Cécile Charpy; Jessica Zucman-Rossi; Nathalie Barget; Olivier Seror; Nathalie Ganne-Carrié; Valérie Paradis; Julien Calderaro
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

6.  A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Authors:  Jian-Hong Fang; Hui-Chao Zhou; Chong Zhang; Li-Ru Shang; Lei Zhang; Jing Xu; Limin Zheng; Yunfei Yuan; Rong-Ping Guo; Wei-Hua Jia; Jing-Ping Yun; Min-Shan Chen; Yaojun Zhang; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

7.  Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.

Authors:  Kohei Shigeta; Meenal Datta; Tai Hato; Shuji Kitahara; Ivy X Chen; Aya Matsui; Hiroto Kikuchi; Emilie Mamessier; Shuichi Aoki; Rakesh R Ramjiawan; Hiroki Ochiai; Nabeel Bardeesy; Peigen Huang; Mark Cobbold; Andrew X Zhu; Rakesh K Jain; Dan G Duda
Journal:  Hepatology       Date:  2019-10-14       Impact factor: 17.425

Review 8.  Vascular normalization as an emerging strategy to enhance cancer immunotherapy.

Authors:  Yuhui Huang; Shom Goel; Dan G Duda; Dai Fukumura; Rakesh K Jain
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

9.  Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Andrew X Zhu; Yoon-Koo Kang; Chia-Jui Yen; Richard S Finn; Peter R Galle; Josep M Llovet; Eric Assenat; Giovanni Brandi; Marc Pracht; Ho Yeong Lim; Kun-Ming Rau; Kenta Motomura; Izumi Ohno; Philippe Merle; Bruno Daniele; Dong Bok Shin; Guido Gerken; Christophe Borg; Jean-Baptiste Hiriart; Takuji Okusaka; Manabu Morimoto; Yanzhi Hsu; Paolo B Abada; Masatoshi Kudo
Journal:  Lancet Oncol       Date:  2019-01-18       Impact factor: 41.316

10.  Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.

Authors:  Lin Tian; Amit Goldstein; Hai Wang; Hin Ching Lo; Ik Sun Kim; Thomas Welte; Kuanwei Sheng; Lacey E Dobrolecki; Xiaomei Zhang; Nagireddy Putluri; Thuy L Phung; Sendurai A Mani; Fabio Stossi; Arun Sreekumar; Michael A Mancini; William K Decker; Chenghang Zong; Michael T Lewis; Xiang H-F Zhang
Journal:  Nature       Date:  2017-04-03       Impact factor: 49.962
  10 in total
  1 in total

Review 1.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.